Indian Company Master Data Made Simple
Sandu Pharmaceuticals Limited
Established in 1985, Sandu Pharmaceuticals Limited has 40 years of operational experience. The company is identified by CIN L24233GA1985PLC001587 and reg. no. 1587. It is officially registered under the category of company limited by shares. The company has an authorized share capital of ₹10.00 crore. Paid-up capital for the company equals ₹9.66 crore.
Sandu Pharmaceuticals Limited primarily operates in manufacture of chemicals and chemical products. The company’s registration location is Goa. The official address of incorporation is Plot No.25,26,29 & 30,pilerne Industrial Estate, Marra, Bardez,goa-403 511., Goa, India, 000000. It is officially listed as an active business entity. For correspondence, the registered email address is [email protected]. The company’s top executive team comprises Vijay Yashwant Kajarekar (CFO).
Profile data last updated: 21/12/2024
Company Overview
- CIN
- Date of Incorporation
- 15/11/1985
- Company Status
- Active
- RoC
- Goa
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹10,00,00,000.00
- Paid up Capital
- ₹9,66,09,900.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹161.58L | ₹118.14L | ₹104.20L | ₹93.65L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹1,370.15L | ₹1,182.23L | ₹1,492.53L | ₹1,281.00L | ₹0.00L |
| Accumulated Depreciation | -₹1,180.14L | -₹1,114.17L | -₹1,057.36L | -₹1,007.51L | ₹0.00L |
| Tangible Book Value | ₹4,199.34L | ₹4,055.78L | ₹3,919.06L | ₹3,643.98L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹5.82L | ₹0.30L | ₹0.00L | ₹0.00L | ₹1.93L |
| Machinery Furniture Equipment | ₹952.05L | ₹905.58L | ₹748.20L | ₹693.37L | ₹0.00L |
| Total Assets | ₹5,571.87L | ₹5,241.49L | ₹5,416.63L | ₹4,928.45L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹4,201.72L | ₹4,059.26L | ₹3,924.10L | ₹3,647.45L | ₹0.00L |
| Gross PPE | ₹2,992.30L | ₹2,898.51L | ₹2,756.07L | ₹2,652.50L | ₹0.00L |
| Total Capitalization | ₹4,201.72L | ₹4,059.26L | ₹3,924.10L | ₹3,647.45L | ₹0.00L |
| Common Stock | ₹966.10L | ₹966.10L | ₹966.10L | ₹881.07L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹2.38L | ₹3.48L | ₹5.04L | ₹3.47L | ₹0.00L |
| Total Debt | ₹47.75L | ₹6.33L | ₹0.00L | ₹0.00L | ₹1.93L |
| Other Equity Interest | ₹3,235.62L | ₹0.02L | -₹0.01L | ₹43.98L | ₹0.00L |
| Capital Stock | ₹966.10L | ₹966.10L | ₹966.10L | ₹881.07L | ₹0.00L |
| Additional Paid In Capital | ₹275.81L | ₹275.81L | ₹275.81L | ₹184.90L | ₹0.00L |
| Total Non Current Assets | ₹2,942.00L | ₹3,011.11L | ₹2,862.12L | ₹2,563.75L | ₹0.00L |
| Invested Capital | ₹4,201.72L | ₹4,059.26L | ₹3,924.10L | ₹3,647.45L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹265.30L | ₹120.63L | ₹229.56L | ₹417.12L | ₹0.00L |
| Net Tangible Assets | ₹4,199.34L | ₹4,055.78L | ₹3,919.06L | ₹3,643.98L | ₹0.00L |
| Prepaid Assets | ₹458.52L | ₹381.47L | ₹371.11L | ₹369.49L | ₹0.00L |
| Cash And Cash Equivalents | ₹130.39L | ₹100.41L | ₹227.56L | ₹93.86L | ₹0.00L |
| Stockholders Equity | ₹4,201.72L | ₹4,059.26L | ₹3,924.10L | ₹3,647.45L | ₹0.00L |
| Other Short Term Investments | ₹134.91L | ₹20.22L | ₹2.00L | ₹323.26L | ₹0.00L |
| Share Issued | ₹96.61L | ₹96.61L | ₹96.61L | ₹88.11L | ₹0.00L |
| Current Assets | ₹2,629.88L | ₹2,230.37L | ₹2,554.50L | ₹2,364.70L | ₹0.00L |
| Working Capital | ₹1,421.31L | ₹1,166.28L | ₹1,166.17L | ₹1,177.35L | ₹0.00L |
| Ordinary Shares Number | ₹96.61L | ₹96.61L | ₹96.61L | ₹88.11L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹41.93L | ₹6.03L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹1,208.57L | ₹1,064.09L | ₹1,388.33L | ₹1,187.35L | ₹0.00L |
| Retained Earnings | ₹952.43L | ₹858.49L | ₹769.22L | ₹667.70L | ₹0.00L |
| Net PPE | ₹1,812.16L | ₹1,784.34L | ₹1,698.71L | ₹1,644.99L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹0.00L | ₹41.96L | ₹48.18L | ₹0.00L |
| Other Non Current Assets | ₹0.04L | -₹0.01L | -₹0.11L | -₹0.02L | ₹0.00L |
| Common Stock Equity | ₹4,201.72L | ₹4,059.26L | ₹3,924.10L | ₹3,647.45L | ₹0.00L |
| Other Intangible Assets | ₹2.38L | ₹3.48L | ₹5.04L | ₹3.47L | ₹0.00L |
| Other Properties | ₹74.59L | ₹70.51L | ₹1,107.51L | ₹1,097.84L | ₹0.00L |
| Inventory | ₹1,414.86L | ₹1,225.06L | ₹1,432.56L | ₹1,127.22L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | ₹29.97L | -₹127.15L | ₹133.69L | -₹358.90L | ₹0.00L |
| Financing Cash Flow | -₹46.24L | -₹72.43L | ₹57.91L | ₹93.43L | ₹0.00L |
| Investing Cash Flow | -₹18.63L | -₹130.71L | ₹53.67L | -₹547.20L | ₹0.00L |
| Free Cash Flow | ₹1.04L | -₹66.52L | -₹84.77L | ₹10.77L | ₹0.00L |
| End Cash Position | ₹130.39L | ₹100.41L | ₹227.56L | ₹93.86L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.01L | ₹0.01L | ₹0.00L | ₹0.00L |
| Capital Expenditure | -₹93.80L | -₹142.51L | -₹106.88L | -₹84.10L | ₹0.00L |
| Beginning Cash Position | ₹100.41L | ₹227.55L | ₹93.86L | ₹452.76L | ₹0.00L |
| Operating Cash Flow | ₹94.84L | ₹75.99L | ₹22.11L | ₹94.87L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Rent Expense Supplemental | ₹23.34L | ₹24.40L | ₹22.35L | ₹21.15L |
| Net Income From Continuing Operation Net Minority Interest | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹292.58L | ₹271.05L | ₹280.56L | ₹295.69L |
| Total Expenses | ₹6,509.82L | ₹6,556.67L | ₹6,337.97L | ₹6,315.65L |
| Operating Revenue | ₹6,719.24L | ₹6,728.07L | ₹6,534.90L | ₹6,550.05L |
| Total Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Income Non Operating | ₹16.75L | ₹42.13L | ₹15.80L | ₹7.63L |
| Interest Expense Non Operating | ₹9.67L | ₹5.43L | ₹7.21L | ₹11.00L |
| Interest Income | ₹16.75L | ₹42.13L | ₹15.80L | ₹7.63L |
| Net Income From Continuing And Discontinued Operation | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| General And Administrative Expense | ₹85.36L | ₹97.47L | ₹90.70L | ₹99.89L |
| Reconciled Depreciation | ₹67.06L | ₹58.33L | ₹51.68L | ₹53.01L |
| Net Income Continuous Operations | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| Reconciled Cost Of Revenue | ₹3,320.44L | ₹3,376.49L | ₹3,225.70L | ₹3,574.28L |
| Net Income | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| Operating Income | ₹209.42L | ₹171.40L | ₹196.93L | ₹234.40L |
| Diluted Average Shares | ₹96.61L | ₹96.61L | ₹94.33L | ₹85.00L |
| Selling And Marketing Expense | ₹1,103.28L | ₹1,171.18L | ₹971.31L | ₹851.38L |
| Total Other Finance Cost | ₹0.66L | ₹0.87L | ₹0.75L | ₹3.61L |
| Normalized Income | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| Net Non Operating Interest Income Expense | ₹6.42L | ₹35.83L | ₹7.84L | -₹11.00L |
| Gross Profit | ₹3,398.80L | ₹3,351.58L | ₹3,309.20L | ₹2,975.77L |
| EBIT | ₹225.52L | ₹212.72L | ₹228.88L | ₹242.68L |
| Cost Of Revenue | ₹3,320.44L | ₹3,376.49L | ₹3,225.70L | ₹3,574.28L |
| Diluted NIAvailto Com Stockholders | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| Net Interest Income | ₹6.42L | ₹35.83L | ₹7.84L | -₹11.00L |
| Operating Expense | ₹3,189.38L | ₹3,180.18L | ₹3,112.27L | ₹2,741.37L |
| Normalized EBITDA | ₹292.58L | ₹271.05L | ₹280.56L | ₹295.69L |
| Net Income Common Stockholders | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| Pretax Income | ₹215.85L | ₹207.29L | ₹221.67L | ₹231.68L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹6,719.24L | ₹6,728.07L | ₹6,534.90L | ₹6,550.05L |
| Selling General And Administration | ₹1,188.64L | ₹1,268.65L | ₹1,062.01L | ₹951.27L |
| Other Operating Expenses | ₹795.03L | ₹810.68L | ₹854.21L | ₹1,797.15L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹9.67L | ₹5.43L | ₹7.21L | ₹11.00L |
| Basic Average Shares | ₹96.61L | ₹96.61L | ₹88.11L | ₹79.87L |
| Tax Provision | ₹60.68L | ₹61.17L | ₹69.62L | ₹72.73L |
| Net Income Including Noncontrolling Interests | ₹155.17L | ₹146.12L | ₹152.05L | ₹158.95L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 23/03/1992 | Umesh Bhaskar Sandu | 01132141 | Managing Director | View other directorships |
| 01/06/2011 | Shashank Bhaskar Sandu | 00678098 | Director | View other directorships |
| 01/04/2015 | Shubhada Prabhakar Sandu | 07148834 | Director | View other directorships |
| 01/04/2015 | Pratika Vishnu Shenvi Dessai | *****2943K | Company Secretary | |
| 14/08/2023 | Balram Viswanathan | 10245195 | Director | View other directorships |
| 14/08/2023 | Ajit Rajaram Kantak | 10269866 | Director | View other directorships |
| 30/03/2024 | Vijay Yashwant Kajarekar | *****1740P | CFO | |
| 12/08/2024 | Vijay Kottapalli | 10245156 | Director | View other directorships |
| 30/09/2024 | Jayshree Bhasker Sandu | 07480177 | Director | View other directorships |
Latest Documents
| Date | Title | Size |
|---|---|---|
| 26/11/2024 | Form MGT-7-25112024 | - |
| 08/11/2024 | Form AOC-4(XBRL)-08112024_signed | - |
| 07/11/2024 | Form AOC-4(XBRL)-24102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
FAQ
The current board member of Sandu Pharmaceuticals Limited are:
- Umesh Bhaskar Sandu
- Shashank Bhaskar Sandu
- Shubhada Prabhakar Sandu
- Jayshree Bhasker Sandu
- Vijay Kottapalli
- Balram Viswanathan
- Ajit Rajaram Kantak